Form 4 Tracker
Janux Therapeutics, Inc.
JANX

11 insider filings · Latest: Jul 8, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 10, 2024Sep 10 8:13 PMReardon Tighe
Proposed Sale
2,055$46.50$95.6K

View →

Sep 9, 2024Sep 9 10:09 PMLichter Jay
Proposed Sale
2,182$42.33$92.4K

View →

Sep 9, 2024Sep 9 10:03 PMReardon Tighe
Proposed Sale
9,269$42.15$390.7K

View →

Sep 9, 2024Sep 9 7:35 PMReardon Tighe
Proposed Sale
5,762$42.12$242.7K

View →

Sep 9, 2024Sep 9 6:28 PMReardon Tighe
Proposed Sale
5,762$42.12$242.7K

View →

Sep 6, 2024Sep 6 11:17 PMAvalon BioVentures I, LP
Proposed Sale
20,991$41.26$866.1K

View →

Sep 6, 2024Sep 6 11:14 PMAvalon BioVentures SPV I, L.P.
Proposed Sale
110,644$41.26$4.6M

View →

Sep 6, 2024Sep 6 11:11 PMAvalon Ventures XI, L.P.
Proposed Sale
108,365$41.26$4.5M

View →

← Previous

Page 5 of 5

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 8, 2026Jul 11 12:00 AMCampbell David AlanDirector, President and CEO
Option Exercise
7,000$4.21697,550(D)

View →

Jun 11, 2026Jun 13 12:30 AMRA CAPITAL MANAGEMENT, L.P.Director, 10% Owner
Grant/Award
15,500$13.6615,500(I)

View →

Jun 11, 2026Jun 13 12:00 AMJake SimsonDirector
Grant/Award
15,500$13.6615,500(D)

View →

Jun 11, 2026Jun 13 12:00 AMWinston KungDirector
Grant/Award
15,500$13.6615,500(D)

View →

Jun 11, 2026Jun 13 12:00 AMNatasha HerndayDirector
Grant/Award
15,500$13.6615,500(D)

View →

Jun 11, 2026Jun 13 12:00 AMEric DobmeierDirector
Grant/Award
15,500$13.6615,500(D)

View →

Jun 11, 2026Jun 13 12:00 AMVickie L CappsDirector
Grant/Award
15,500$13.6615,500(D)

View →

Jun 11, 2026Jun 13 12:00 AMRonald W BarrettDirector
Grant/Award
15,500$13.6615,500(D)

View →

Feb 2, 2026Feb 5 1:01 AMWilliam GoChief Medical Officer
Grant/Award
154,000$13.99154,000(D)

View →